Your browser doesn't support javascript.
loading
Selatogrel, a reversible P2Y12 receptor antagonist, has reduced off-target interference with haemostatic factors in a mouse thrombosis model.
Crescence, Lydie; Darbousset, Roxane; Caroff, Eva; Hubler, Francis; Riederer, Markus A; Panicot-Dubois, Laurence; Dubois, Christophe.
Afiliação
  • Crescence L; Aix Marseille Université, INSERM 1263, INRAE 1260 27 Boulevard Jean Moulin, Marseille, France.
  • Darbousset R; Aix Marseille Université, INSERM 1263, INRAE 1260 27 Boulevard Jean Moulin, Marseille, France.
  • Caroff E; Idorsia Pharmaceuticals Ltd. DD Chemistry, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland.
  • Hubler F; Idorsia Pharmaceuticals Ltd. DD Chemistry, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland.
  • Riederer MA; Idorsia Pharmaceuticals Ltd. DD Biology, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland. Electronic address: markus.riederer@idorsia.com.
  • Panicot-Dubois L; Aix Marseille Université, INSERM 1263, INRAE 1260 27 Boulevard Jean Moulin, Marseille, France.
  • Dubois C; Aix Marseille Université, INSERM 1263, INRAE 1260 27 Boulevard Jean Moulin, Marseille, France.
Thromb Res ; 200: 133-140, 2021 04.
Article em En | MEDLINE | ID: mdl-33610885

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Hemostáticos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Hemostáticos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França